课题基金 / 基金详情

15N LABELING OF ANTI HIV I RIBOZYME

15N LABELING OF ANTI HIV I RIBOZYME
抗 HIV I 核酶的 15N 标记
批准号:
6309036
负责人:
RAMASWAMY H SARMA
金额:
$2.74万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-01 至 2002-01-14

项目摘要

项目成果

RAMASWAMY H SARMA的其他基金

相似基金

相关文献

中文摘要
翻译
SIR提供了13 C,N DNA; 50 mg由于它们的能力, 通过沃森-克里克碱基特异识别靶序列 配对,抗sese NDA/RNA已被证明是一种有效的工具, 破坏了病毒的生命周期 最近的研究表明, 小型植物中催化RNA种类分离 病原性RNA进一步增强了 反义寡核苷酸通过克服其化学计量 要求。 我们正在研究一个30聚体 核酶和HIV-1GAG-RNA的17-mer DNA类似物。 统一使用 标记的DNA,我们将采用3和4-D NMR技术来确定 结构
英文摘要
The SIR provided 13C, "N DNA; 50mg Due to their ability ot specifically recognize targeted sequences through Watson-Crick base pairing, anti-sese NDA/RNA have been shown to be an effective tool in distrpting the life cycle of a virus. Recently it has been shown that the incorporationo f catalytic RNA species derived from small plant pathogenic RNA's further enhanced the therapeutic ability of anti-sense oligonucleotides by overcoming its stoichiometrical requirement. We are studying the abortive complex between a 30-mer ribozyme and a 17-mer DNA analog of HIV- I GAG-RNA. Using uniformly labeled DNA we will employ 3 and 4-D NMR techniques to determine the structure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Albany 2013: The 18th Conversation
Albany 2011: The 17th Conversation
Albany 2009: The 16th Conversation
Albany 2007: The 15th Conversation
海外基金